TDMS Study 92012-03 Pathology Tables
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 15:20:50 90-DAY SUBCHRONIC Facility: Microbiological Associates Chemical CAS #: 693-98-1 Lock Date: 08/31/94 Cage Range: All Reasons For Removal: All Removal Date Range: All Treatment Groups: Include All a Number of animals examined microscopically at site and number of animals with lesion Page 1 NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 15:20:50 ____________________________________________________________________________________________________________________________________ FISCHER 344 RATS FEMALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Survivors Accidently Killed 3 3 2 5 Terminal Sacrifice 7 10 10 7 8 5 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ Page 2 NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 15:20:50 ____________________________________________________________________________________________________________________________________ FISCHER 344 RATS FEMALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 3 NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 15:20:50 ____________________________________________________________________________________________________________________________________ FISCHER 344 RATS MALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Survivors Terminal Sacrifice 10 10 10 10 10 10 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM Thyroid Gland (10) (10) (10) (10) (10) (10) Follicular Cell, Adenoma 2 (20%) ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ Page 4 NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 15:20:50 ____________________________________________________________________________________________________________________________________ FISCHER 344 RATS MALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 5 NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 15:20:50 ____________________________________________________________________________________________________________________________________ FISCHER 344 RATS MALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ TUMOR SUMMARY Total Animals with Primary Neoplasms (b) 2 Total Primary Neoplasms 2 Total Animals with Benign Neoplasms 2 Total Benign Neoplasms 2 Total Animals with Malignant Neoplasms Total Malignant Neoplasms Total Animals with Metastatic Neoplasms Total Metastatic Neoplasm Total Animals with Malignant Neoplasms Uncertain Primary Site Total Animals with Neoplasms Uncertain- Benign or Malignant Total Uncertain Neoplasms ____________________________________________________________________________________________________________________________________ a Number of animals examined microscopically at site and number of animals with lesion b Primary tumors: all tumors except metastatic tumors Page 6 ------------------------------------------------------------ ---------- END OF REPORT ---------- ------------------------------------------------------------